Reimagining Oncology Education With Human-Guided AI
Read the full article here: https://oncdata.com/reimagining-oncology-education-with-ai New clinical trials, guideline updates, therapeutic a...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Oncology Data Advisor
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
Episodes
20 of 452 episodes
Personalizing Surgical Risk Assessment in Lung Cancer With AI
Read the full article here: https://oncdata.com/personalizing-surgical-risk-assessment-in-lung-cancer For many patients with lung cancer, su...
Clinical Trial Enrollment Barriers: Awareness Isn’t the Same as Access
Check out the full article at: https://oncdata.com/oncology-unfiltered-clinical-trial-enrollment-barriers While clinical trials represent th...
Building Trust in Real-World Evidence With AI and High-Quality Data
Read the full article at: https://oncdata.com/real-world-evidence-ai-in-oncology Artificial intelligence (AI) is rapidly transforming oncolo...
One Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging
Read the full article at: https://oncdata.com/personalizing-cancer-prevention-ai-enhanced-imaging As healthcare increasingly shifts from rea...
AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) c...
Advancing Extrapulmonary NEC: DLL3 & Beyond
Are you treating extrapulmonary neuroendocrine carcinomas based on where they start—or what they actually are? In this faculty follow-up to...
Prostate Cancer Breakthroughs: TALAPRO-3, PROTEUS, & Earlier Therapy
What if hitting prostate cancer earlier and harder is the key to delaying disease progression and sparing patients from invasive salvage the...
Advances in CIDP: Consensus Definitions, Emerging Pipeline & Individualized Care
Chronic inflammatory demyelinating polyneuropathy (CIDP) presents significant challenges in both diagnosis and long-term disease management....
Information Overload and the Portal Patient: The Era of Instant Test Results
Read the full article here: https://oncdata.com/information-overload-and-the-portal-patient The way that patients receive medical informatio...
One Size Fits One: Personalizing Cancer Prevention Through AI-Enhanced Imaging
Read the full article here! https://oncdata.com/personalizing-cancer-prevention-ai-enhanced-imaging As healthcare increasingly shifts from r...
Precision Decisions in NDMM: Live Virtual Rounds Preview
Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38...
Multidisciplinary Realities: Tumor Board vs Tuesday Afternoon
View the full article at: https://oncdata.com/oncology-unfiltered-tumor-board-vs-tuesday-afternoon Tumor boards play a pivotal role in oncol...
The Real World vs The Trial Patient: Bridging the Gap
Check out the full article at: https://oncdata.com/oncology-unfiltered-the-real-world-vs-the-trial-patient Every oncologist knows the moment...
AI-Driven Pathological Subtyping for Pancreatic Cancer: Moving From Promise to Practical Application
Read the full article at: https://oncdata.com/ai-driven-pathological-subtyping-pancreatic-cancer-ashish-manne Artificial intelligence (AI) c...
Solving the PFIC Mystery: Genetic Testing and Diagnosis in Adults
Think PFIC is only a pediatric disease? Think again. Progressive Familial Intrahepatic Cholestasis (PFIC) was long considered a condition ex...
HelioLiver: Expanding Early Detection of Hepatocellular Carcinoma With AI
Read the full article at: https://oncdata.com/exploring-ai-helioliver Patients diagnosed with early-stage liver cancer have a significantly...
New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian
The treatment of esophagogastric cancer is undergoing a profound transformation. In this episode, Yelena Janjigian, MD (MSKCC), discusses ho...
HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib
Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! https://i3...
Choosing Not to Treat: How Do You Know When the Best Treatment Is No Treatment?
Choosing Not to Treat: How Do You Know When the Best Treatment Is No Treatment? by i3 Health